180 related articles for article (PubMed ID: 16020911)
1. Analysis of the global RNA expression profiles of skeletal muscle cells treated with statins.
Morikawa S; Murakami T; Yamazaki H; Izumi A; Saito Y; Hamakubo T; Kodama T
J Atheroscler Thromb; 2005; 12(3):121-31. PubMed ID: 16020911
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin and pitavastatin enhance lipoprotein lipase production in L6 skeletal muscle cells through activation of adenosine monophosphate-activated protein kinase.
Ohira M; Endo K; Saiki A; Miyashita Y; Terai K; Murano T; Watanabe F; Tatsuno I; Shirai K
Metabolism; 2012 Oct; 61(10):1452-60. PubMed ID: 22520230
[TBL] [Abstract][Full Text] [Related]
3. High doses of atorvastatin and simvastatin induce key enzymes involved in VLDL production.
Roglans N; Verd JC; Peris C; Alegret M; Vázquez M; Adzet T; Díaz C; Hernández G; Laguna JC; Sánchez RM
Lipids; 2002 May; 37(5):445-54. PubMed ID: 12056585
[TBL] [Abstract][Full Text] [Related]
4. Synergistic action of statins and nitrogen-containing bisphosphonates in the development of rhabdomyolysis in L6 rat skeletal myoblasts.
Nishiguchi T; Akiyoshi T; Anami S; Nakabayashi T; Matsuyama K; Matzno S
J Pharm Pharmacol; 2009 Jun; 61(6):781-8. PubMed ID: 19505369
[TBL] [Abstract][Full Text] [Related]
5. Influence of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ubiquinone levels in rat skeletal muscle and heart: relationship to cytotoxicity and inhibitory activity for cholesterol synthesis in human skeletal muscle cells.
Yamazaki H; Suzuki M; Aoki T; Morikawa S; Maejima T; Sato F; Sawanobori K; Kitahara M; Kodama T; Saito Y
J Atheroscler Thromb; 2006 Dec; 13(6):295-307. PubMed ID: 17192694
[TBL] [Abstract][Full Text] [Related]
6. Human skeletal muscle drug transporters determine local exposure and toxicity of statins.
Knauer MJ; Urquhart BL; Meyer zu Schwabedissen HE; Schwarz UI; Lemke CJ; Leake BF; Kim RB; Tirona RG
Circ Res; 2010 Feb; 106(2):297-306. PubMed ID: 19940267
[TBL] [Abstract][Full Text] [Related]
7. Statin-induced apoptosis linked with membrane farnesylated Ras small G protein depletion, rather than geranylated Rho protein.
Matzno S; Yasuda S; Juman S; Yamamoto Y; Nagareya-Ishida N; Tazuya-Murayama K; Nakabayashi T; Matsuyama K
J Pharm Pharmacol; 2005 Nov; 57(11):1475-84. PubMed ID: 16259781
[TBL] [Abstract][Full Text] [Related]
8. Pitavastatin enhanced lipoprotein lipase expression in 3T3-L1 preadipocytes.
Saiki A; Murano T; Watanabe F; Oyama T; Miyashita Y; Shirai K
J Atheroscler Thromb; 2005; 12(3):163-8. PubMed ID: 16020917
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells.
Narumiya H; Sasaki S; Kuwahara N; Irie H; Kusaba T; Kameyama H; Tamagaki K; Hatta T; Takeda K; Matsubara H
Cardiovasc Res; 2004 Nov; 64(2):331-6. PubMed ID: 15485693
[TBL] [Abstract][Full Text] [Related]
10. Statins reduce amyloid β-peptide production by modulating amyloid precursor protein maturation and phosphorylation through a cholesterol-independent mechanism in cultured neurons.
Hosaka A; Araki W; Oda A; Tomidokoro Y; Tamaoka A
Neurochem Res; 2013 Mar; 38(3):589-600. PubMed ID: 23269484
[TBL] [Abstract][Full Text] [Related]
11. The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells.
Morikawa S; Takabe W; Mataki C; Kanke T; Itoh T; Wada Y; Izumi A; Saito Y; Hamakubo T; Kodama T
J Atheroscler Thromb; 2002; 9(4):178-83. PubMed ID: 12226549
[TBL] [Abstract][Full Text] [Related]
12. Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance.
Muraki A; Miyashita K; Mitsuishi M; Tamaki M; Tanaka K; Itoh H
J Appl Physiol (1985); 2012 Aug; 113(3):479-86. PubMed ID: 22653988
[TBL] [Abstract][Full Text] [Related]
13. Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a 'mitohormesis' mechanism involving reactive oxygen species and PGC-1.
Bouitbir J; Charles AL; Echaniz-Laguna A; Kindo M; Daussin F; Auwerx J; Piquard F; Geny B; Zoll J
Eur Heart J; 2012 Jun; 33(11):1397-407. PubMed ID: 21775390
[TBL] [Abstract][Full Text] [Related]
14. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase the binding activity and nuclear level of Oct-1 in mononuclear cells.
Ortego M; Hernández AG; Bustos C; Blanco-Colio LM; Hernández-Presa MA; Tuñón J; Egido J
Eur J Pharmacol; 2002 Jul; 448(2-3):113-21. PubMed ID: 12144930
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropic effects of statins in atherosclerosis and diabetes.
Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific effects of atorvastatin on 3-hydroxy-3-methylglutarylcoenzyme A reductase expression and activity in spontaneously hypertensive rats.
Chen GP; Yao L; Lu X; Li L; Hu SJ
Acta Pharmacol Sin; 2008 Oct; 29(10):1181-6. PubMed ID: 18817622
[TBL] [Abstract][Full Text] [Related]
17. Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells.
Schönbeck U; Gerdes N; Varo N; Reynolds RS; Horton DB; Bavendiek U; Robbie L; Ganz P; Kinlay S; Libby P
Circulation; 2002 Dec; 106(23):2888-93. PubMed ID: 12460867
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.
Wassmann S; Laufs U; Bäumer AT; Müller K; Konkol C; Sauer H; Böhm M; Nickenig G
Mol Pharmacol; 2001 Mar; 59(3):646-54. PubMed ID: 11179461
[TBL] [Abstract][Full Text] [Related]
19. Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice.
Vecchione C; Brandes RP
Circ Res; 2002 Jul; 91(2):173-9. PubMed ID: 12142351
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-CoA reductase feedback regulation.
Chen Y; Ku H; Zhao L; Wheeler DC; Li LC; Li Q; Varghese Z; Moorhead JF; Powis SH; Huang A; Ruan XZ
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):365-76. PubMed ID: 24233489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
